Eventide Asset Management »

Nektar Therapeutics shares owned by Eventide Asset Management

Quarter-by-quarter ownership of Nektar Therapeutics (NKTR) shares owned by Eventide Asset Management from 13F filings

Historical chart of Eventide Asset Management investment in Nektar Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Nektar Therapeutics held by Eventide Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nektar Therapeutics by Eventide Asset Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $9.3M 7.5M 1.24

More positions owned by Eventide Asset Management

Trane Technologies SHS (TT)
Transmedics Group (TMDX)
Waste Connections (WCN)
Roper Industries (ROP)
Old Dominion Freight Line (ODFL)
Datadog Cl A Com (DDOG)
The Trade Desk Com Cl A (TTD)
Mirum Pharmaceuticals (MIRM)
Celldex Therapeutics Com New (CLDX)
D.R. Horton (DHI)
Guardant Health (GH)
Lam Research Corporation (LRCX)
Mettler-Toledo International (MTD)
Crowdstrike Hldgs Cl A (CRWD)
Argenx Se Sponsored Adr (ARGX)

View all positions for Eventide Asset Management

Top funds holding Nektar Therapeutics

Deep Track Capital
BlackRock
Vanguard Group
Samlyn Capital
Eventide Asset Management
Citadel Advisors
PRIMECAP Management Company
Acadian Asset Management
Millennium Management
Geode Capital Management
Nantahala Capital Management
TCG Crossover Management
Renaissance Technologies
State Street Corporation
Jacobs Levy Equity Management

View all funds holding Nektar Therapeutics